Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Metabolic Associated Fatty Liver DiseasePancreatic SteatosisObeseLeanChronic Hepatitis B
Interventions
DEVICE

Abdominal Ultrasound

Standard abdominal ultrasonography performed to evaluate pancreatic steatosis by comparing pancreatic echogenicity to liver and kidney tissue.

DEVICE

Transient elastography

Non-invasive transient elastography used to assess hepatic steatosis and liver stiffness in patients with chronic hepatitis B.

DIAGNOSTIC_TEST

Waist Circumference

The midpoint between the superior aspect of the iliac crests and the lower lateral margins of the ribs using an inelastic tape (TBW Import Ltd) that was 0.5 cm in width and 200 cm in length, according to World Health Organization (WHO) recommendations. Abdominal obesity, determined as a waist circumference of ≥94 cm in males or ≥80 cm in females according to the recommendations of the International Diabetes Federation group

DIAGNOSTIC_TEST

Body mass index

"It was calculated by the equation dividing the weight in kilograms by height in meters squared.~BMI=〖mass〗\_kg/(〖height〗\_m\^2 )"

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER